News

Oracle (ORCL) Launches Defense Ecosystem to Advance AI and Cloud Innovation in National Security
Oracle Corporation (NYSE:ORCL) is one of the 13 best software stocks to buy now. On June 17, Oracle introduced the Oracle ...
MedPage Today1h
3 Dead in Pasta-Linked Outbreak; FDA Gene Tx Officials Ousted; Mpox on Cruise Ships
Note that some links may require registration or subscription. Three people died and 16 have been hospitalized in a listeria ...
STAT1h
Pharmalittle: We’re reading about FDA forcing out top gene therapy regulator, Gilead’s HIV challenges and more
And more pharma news updates from Pharmalittle.
Bill Gates reveals 'next phase of Alzheimer's fight' as he shares dad's personal battle
Microsoft co-founder Bill Gates reflects on his father's Alzheimer's battle and expresses optimism about advancements in ...
Lilly to appeal as U.K. declines to endorse use of new Alzheimer’s drugs
Eli Lilly (NYSE:LLY) announced it would appeal a decision by the U.K. health authorities not to recommend the company’s new ...
Taiwan News7h
New Alzheimer’s drug to be administered in Taiwan
TAIPEI (Taiwan News) — Far Eastern Memorial Hospital is set to become the first medical institution in Taiwan to administer ...
Family And Friends Shoulder The Real Cost Of Dementia − $224B In Unpaid Care
About 5.5 million Americans live with dementia, requiring US$53 billion in annual medical spending on doctor visits, hospitalizations, medications, h ...
UK health service rejects costly, 'low benefit' Alzheimer's drugs
The UK's state-run health service said Thursday it will not offer two new treatments for Alzheimer's disease, citing high ...
The Pharma Letter23h
BRIEF—NICE can’t justify cost to the NHS to approve Kisluna
The benefits from Eli Lilly’s Kisulna (donanemab) remain too small to justify the additional cost to the National Health Service (NHS), said the UK health technology assessor the National Institute ...